Cash Flow Statement
Growth Metrics

Xtant Medical Holdings (XTNT) Revenue Growth (3y) (2013 - 2025)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue Growth (3y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 4.63%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 8.01%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 5.28%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 15.36%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 10.52%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 0.73%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 17.14%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 2.92%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 7.43%
10 Xtant Medical Holdings 64.46 Mn 47.14 Mn 17.75 Mn -

Historic Data

Download Data 🔒
DateValue
Sep 30, 2025 31.99%
Jun 30, 2025 32.34%
Mar 31, 2025 36.46%
Dec 31, 2024 31.15%
Sep 30, 2024 26.68%
Jun 30, 2024 25.98%
Mar 31, 2024 30.61%
Dec 31, 2023 26.11%
Sep 30, 2023 21.41%
Jun 30, 2023 24.46%
Mar 31, 2023 6.68%
Dec 31, 2022 -3.13%
Sep 30, 2022 -2.74%
Jun 30, 2022 0.18%
Mar 31, 2022 -8.18%
Dec 31, 2021 -9.07%
Sep 30, 2021 -7.32%
Jun 30, 2021 -7.06%
Mar 31, 2021 -11.32%
Dec 31, 2020 -20.12%
Sep 30, 2020 -10.94%
Jun 30, 2020 -21.11%
Mar 31, 2020 -12.53%
Dec 31, 2019 -12.39%
Sep 30, 2019 -11.79%
Jun 30, 2019 -10.66%
Mar 31, 2019 -7.27%
Dec 31, 2018 -5.84%
Sep 30, 2018 -0.81%
Jun 30, 2018 23.54%
Mar 31, 2018 23.58%
Dec 31, 2017 41.93%
Sep 30, 2017 33.88%
Jun 30, 2017 34.85%
Mar 31, 2017 35.31%
Dec 31, 2016 42.44%
Sep 30, 2016 42.42%
Jun 30, 2016 37.51%
Mar 31, 2016 34.51%
Dec 31, 2015 40.73%
Sep 30, 2015 26.97%
Jun 30, 2015 6.83%
Mar 31, 2015 6.94%
Dec 31, 2014 1.86%
Sep 30, 2014 3.03%
Jun 30, 2014 5.75%
Mar 31, 2014 14.94%
Dec 31, 2013 19.34%
Sep 30, 2013 25.15%
Jun 30, 2013 36.81%